Cite This Page
Bibliographic details for Technology involving iPSCderived insulinproducing cells through patients with variety One and type Two diabetic issues in comparison with wholesome manage
- Page name: Technology involving iPSCderived insulinproducing cells through patients with variety One and type Two diabetic issues in comparison with wholesome manage
- Author: OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK contributors
- Publisher: OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK, .
- Date of last revision: 20 January 2024 08:41 UTC
- Date retrieved: 8 May 2024 06:19 UTC
- Permanent URL: https://news.npo.digital/index.php?title=Technology_involving_iPSCderived_insulinproducing_cells_through_patients_with_variety_One_and_type_Two_diabetic_issues_in_comparison_with_wholesome_manage&oldid=578592
- Page Version ID: 578592
Citation styles for Technology involving iPSCderived insulinproducing cells through patients with variety One and type Two diabetic issues in comparison with wholesome manage
APA style
Technology involving iPSCderived insulinproducing cells through patients with variety One and type Two diabetic issues in comparison with wholesome manage. (2024, January 20). OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK, . Retrieved 06:19, May 8, 2024 from https://news.npo.digital/index.php?title=Technology_involving_iPSCderived_insulinproducing_cells_through_patients_with_variety_One_and_type_Two_diabetic_issues_in_comparison_with_wholesome_manage&oldid=578592.
MLA style
"Technology involving iPSCderived insulinproducing cells through patients with variety One and type Two diabetic issues in comparison with wholesome manage." OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK, . 20 Jan 2024, 08:41 UTC. 8 May 2024, 06:19 <https://news.npo.digital/index.php?title=Technology_involving_iPSCderived_insulinproducing_cells_through_patients_with_variety_One_and_type_Two_diabetic_issues_in_comparison_with_wholesome_manage&oldid=578592>.
MHRA style
OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK contributors, 'Technology involving iPSCderived insulinproducing cells through patients with variety One and type Two diabetic issues in comparison with wholesome manage', OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK, , 20 January 2024, 08:41 UTC, <https://news.npo.digital/index.php?title=Technology_involving_iPSCderived_insulinproducing_cells_through_patients_with_variety_One_and_type_Two_diabetic_issues_in_comparison_with_wholesome_manage&oldid=578592> [accessed 8 May 2024]
Chicago style
OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK contributors, "Technology involving iPSCderived insulinproducing cells through patients with variety One and type Two diabetic issues in comparison with wholesome manage," OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK, , https://news.npo.digital/index.php?title=Technology_involving_iPSCderived_insulinproducing_cells_through_patients_with_variety_One_and_type_Two_diabetic_issues_in_comparison_with_wholesome_manage&oldid=578592 (accessed May 8, 2024).
CBE/CSE style
OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK contributors. Technology involving iPSCderived insulinproducing cells through patients with variety One and type Two diabetic issues in comparison with wholesome manage [Internet]. OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK, ; 2024 Jan 20, 08:41 UTC [cited 2024 May 8]. Available from: https://news.npo.digital/index.php?title=Technology_involving_iPSCderived_insulinproducing_cells_through_patients_with_variety_One_and_type_Two_diabetic_issues_in_comparison_with_wholesome_manage&oldid=578592.
Bluebook style
Technology involving iPSCderived insulinproducing cells through patients with variety One and type Two diabetic issues in comparison with wholesome manage, https://news.npo.digital/index.php?title=Technology_involving_iPSCderived_insulinproducing_cells_through_patients_with_variety_One_and_type_Two_diabetic_issues_in_comparison_with_wholesome_manage&oldid=578592 (last visited May 8, 2024).
BibTeX entry
@misc{ wiki:xxx, author = "OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK", title = "Technology involving iPSCderived insulinproducing cells through patients with variety One and type Two diabetic issues in comparison with wholesome manage --- OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK{,} ", year = "2024", url = "https://news.npo.digital/index.php?title=Technology_involving_iPSCderived_insulinproducing_cells_through_patients_with_variety_One_and_type_Two_diabetic_issues_in_comparison_with_wholesome_manage&oldid=578592", note = "[Online; accessed 8-May-2024]" }
When using the LaTeX package url (\usepackage{url}
somewhere in the preamble) which tends to give much more nicely formatted web addresses, the following may be preferred:
@misc{ wiki:xxx, author = "OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK", title = "Technology involving iPSCderived insulinproducing cells through patients with variety One and type Two diabetic issues in comparison with wholesome manage --- OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK{,} ", year = "2024", url = "\url{https://news.npo.digital/index.php?title=Technology_involving_iPSCderived_insulinproducing_cells_through_patients_with_variety_One_and_type_Two_diabetic_issues_in_comparison_with_wholesome_manage&oldid=578592}", note = "[Online; accessed 8-May-2024]" }